Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.

Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol. 1998 Apr; 8(2):263-76.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.